36 Participants Needed

Spinal Cord Stimulation for Spinal Cord Injury

Recruiting at 1 trial location
JB
JR
Overseen ByJames R McIntosh, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have stimulation devices in the neck or chest, you may not be eligible to participate.

What data supports the effectiveness of the treatment Intraoperative stimulation of the cervical spinal cord for spinal cord injury?

Spinal cord stimulation (SCS) has shown promise in restoring function after spinal cord injuries, as it is driven by advances in understanding spinal cord lesions and compensatory mechanisms. Although primarily used for pain management, new strategies like spatiotemporal neuromodulation, combined with intensive rehabilitation, are being explored for their potential to improve outcomes in spinal cord injury patients.12345

Is spinal cord stimulation generally safe for humans?

Spinal cord stimulation, including cervical spinal cord stimulation, is generally considered safe with a low risk of complications. In a large study, the rate of spinal cord injury was 0.5%, and other complications were also relatively low, with no deaths reported.26789

How is intraoperative stimulation of the cervical spinal cord different from other treatments for spinal cord injury?

Intraoperative stimulation of the cervical spinal cord is unique because it involves direct electrical stimulation during surgery, which may allow for precise targeting and immediate feedback on its effects, unlike other treatments that are typically administered post-surgery or through less direct methods.45101112

What is the purpose of this trial?

The proposed study seeks to understand how the cervical spinal cord should be stimulated after injury through short-term physiology experiments that will inform a preclinical efficacy trial. The purpose of this study is to determine which cervical levels epidural electrical stimulation (EES) should target to recruit arm and hand muscles effectively and selectively in spinal cord injury (SCI).

Eligibility Criteria

This trial is for individuals who need cervical spine surgery due to conditions like a broken neck, spinal cord injury, or quadriplegia. It's not open to those with stimulation devices in the neck or chest, such as vagal nerve stimulators or pacemakers.

Inclusion Criteria

I need surgery for my neck spine.

Exclusion Criteria

Stimulation devices in the neck or chest (e.g., vagal nerve stimulation, cardiac patients with pacemakers)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intraoperative Testing

Motor evoked responses to epidural electrical stimulation (EES) will be tested at cervical segments with and without myelopathy

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after intraoperative testing

4 weeks

Treatment Details

Interventions

  • Intraoperative stimulation of the cervical spinal cord
Trial Overview The study is testing how stimulating the cervical spinal cord during surgery can help arm and hand muscle function after a spinal injury. Researchers want to find out which parts of the cervical spine should be targeted for optimal recovery.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Arm 1 - Intraoperative ParticipantsExperimental Treatment1 Intervention
Motor evoked responses responses (MEPs) to epidural electrical stimulation (EES) will be tested at cervical segments with and without myelopathy in participants with cervical myelopathy.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Findings from Research

The median time to explantation of high frequency 10 kHz spinal cord stimulators was found to be 3.5 years, with significant explantation rates of 11.1% at 1 year, 22.2% at 2 years, and 32.5% at 3 years among 126 patients studied.
Despite previous studies showing high efficacy of high frequency SCS for lower and leg pain, this study revealed a higher than expected explantation rate, highlighting the need for more longitudinal data to assess the long-term effectiveness and safety of this treatment.
Explantation Rates of High Frequency Spinal Cord Stimulation in Two Outpatient Clinics.Wang, VC., Bounkousohn, V., Fields, K., et al.[2022]
In a study analyzing 2053 cases of cervical spinal cord stimulation (cSCS) from 2002 to 2011, the rate of spinal cord injury was found to be 0.5%, which is higher than previously reported, indicating a need for careful patient selection and counseling.
Despite the spinal cord injury rate, cSCS remains a relatively safe procedure with low rates of other complications (1.1% neurological, 1.4% medical, and 11.7% general perioperative complications), making it a viable option for pain management in patients, especially in an aging population reliant on opioids.
Rate of perioperative neurological complications after surgery for cervical spinal cord stimulation.Chan, AK., Winkler, EA., Jacques, L.[2017]
Spinal cord stimulation (SCS) is evolving from a treatment for intractable pain to a potential method for restoring function after spinal cord injuries, driven by advances in understanding spinal cord lesions and compensatory mechanisms.
New SCS strategies, like spatiotemporal neuromodulation, show promise but require intensive rehabilitation techniques to be effective, highlighting the need for well-designed clinical trials to evaluate safety and efficacy in real-world applications.
Advances in Spinal Cord Neuromodulation: The Integration of Neuroengineering, Computational Approaches, and Innovative Conceptual Frameworks.Pradat, PF., Hayon, D., Blancho, S., et al.[2023]

References

Explantation Rates of High Frequency Spinal Cord Stimulation in Two Outpatient Clinics. [2022]
Rate of perioperative neurological complications after surgery for cervical spinal cord stimulation. [2017]
Advances in Spinal Cord Neuromodulation: The Integration of Neuroengineering, Computational Approaches, and Innovative Conceptual Frameworks. [2023]
Electrophysiologic monitoring for placement of laminectomy leads for spinal cord stimulation under general anesthesia. [2022]
Implantation of Surgical Paddle Electrodes Using Percutaneous Biportal-Endoscopic Technique for Spinal Cord Stimulation: An Anatomical Feasibility Study in Human Cadavers. [2023]
Multiphase Spinal Cord Stimulation in Participants With Chronic Back or Leg Pain: Results of the BENEFIT-02 Randomized Clinical Trial. [2023]
Rate of Complications Following Spinal Cord Stimulation Paddle Electrode Removal. [2022]
Effects of epidural electrical stimulation modalities on spinal cord function and morphology in cats. [2013]
Cortical evoked potentials used for placement of a laminotomy lead array: a case report. [2022]
[Spinal cord stimulation and failed back surgery syndrome. Clinical results with laminectomy electrodes]. [2015]
Spinal cord stimulation for chronic pain. [2018]
12.United Statespubmed.ncbi.nlm.nih.gov
Spinal cord stimulation electrode design: prospective, randomized, controlled trial comparing percutaneous and laminectomy electrodes-part I: technical outcomes. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security